Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Gabriela Kłodowska-Duda | Researchclopedia

Back to researchers

Gabriela Kłodowska-Duda

33

Works

1,879

Citations

19

h-index

21

i10-index

Research Topics

Parkinson's Disease Mechanisms and Treatments Neurological disorders and treatments Genetic Neurodegenerative Diseases

Affiliations

Medical University of Silesia2002–2012

Śląska Wyższa Szkoła Informatyczno-Medyczna2006–2006

Górnośląskie Centrum Medyczne2004–2006

Central Clinical Hospital2005–2005

Top Works

Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension

Raju Kapoor,Pei‐Ran Ho,et al.

2018330 citations

RNA regulation and disease

Autism Spectrum Disorder Research

Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial

Diego Cadavid,Michelle Mellion,et al.

2019177 citations

Safety and tolerability of inebilizumab (MEDI-551), an anti-CD19 monoclonal antibody, in patients with relapsing forms of multiple sclerosis: Results from a phase 1 randomised, placebo-controlled, escalating intravenous and subcutaneous dose study

Mark Agius,Gabriela Kłodowska-Duda,et al.

2017139 citations

The association of functional catechol-O-methyltransferase haplotypes with risk of Parkinson's disease, levodopa treatment response, and complications

Monika Białecka,Mateusz Kurzawski,et al.

200898 citations

CARD15 variants in patients with sporadic Parkinson's disease

Monika Białecka,Mateusz Kurzawski,et al.

200676 citations

The effect of monoamine oxidase B (MAOB) and catechol-O-methyltransferase (COMT) polymorphisms on levodopa therapy in patients with sporadic Parkinson's disease

Monika Białecka,Marek Droździk,et al.

200473 citations

Safety and efficacy of continuous subcutaneous levodopa–carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial

Alberto J. Espay,Fabrizio Stocchi,et al.

202464 citations

Interleukin-10 (IL10) and tumor necrosis factor α (TNF) gene polymorphisms in Parkinson's disease patients

Monika Białecka,Gabriela Kłodowska-Duda,et al.

200857 citations

Mitochondrial DNA haplogroups and subhaplogroups are associated with Parkinson’s disease risk in a Polish PD cohort

Katarzyna Gawęda-Walerych,Aleksandra Maruszak,et al.

200856 citations